Skip to main content
. 2021 Mar 30;9(4):357. doi: 10.3390/biomedicines9040357

Figure 7.

Figure 7

Viability of HL60/MDR cells treated for 48 h by doxorubicin (DOXO) at a concentration of 1 μM in the presence or absence of the flavonoids (10, 9, 7, 6 and 5) or verapamil (VERA), all at a concentration of 20 μM. The viability of cells after treatment with doxorubicin alone was compared with viability after treatment with doxorubicin in combination with the flavonoid or verapamil used as a positive control. The data show the means ± SD of at least three independent experiments. (* p < 0.05; ** p < 0.005).